Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD

Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice

(2018) Parvin Ghareghani et al.   Obesity Research & Clinical Practice

Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism

(2017) Preeti Pathak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance

(2017) Neetu Sud et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Differential expression of microRNAs following cardiopulmonary bypass in children with congenital heart diseases

(2017) Masood Abu-Halima et al.   Journal of Translational Medicine

The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH

(2017) Daniela Gabbia et al.   Marine Drugs

Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model

(2017) Hualin Wang et al.   Biomed Research International

Expression Profile of Genes Potentially Associated with Adequate Glycemic Control in Patients with Type 2 Diabetes Mellitus

(2017) Sâmia Cruz Tfaile Corbi et al.   Journal of Diabetes Research

Gene expression profiling and functional analysis reveals that p53 pathway-related gene expression is highly activated in cancer cells treated by cold atmospheric plasma-activated medium

(2017) Lei Shi et al.   PeerJ

Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients

(2017) Bin Zhou et al.   Scientific Reports

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice

(2017) Lan N. Tu et al.   Scientific Reports

Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing

(2017) Annelynn Wallaert et al.   Scientific Reports

Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease

(2016) Chunhua Wang et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?

(2016) Peter Willeit et al.   EUROPEAN HEART JOURNAL

Versican: a novel modulator of hepatic fibrosis

(2016) Terence N Bukong et al.   LABORATORY INVESTIGATION

Hepatic miR-33a/miR-144 and their target geneABCA1are associated with steatohepatitis in morbidly obese subjects

(2016) Joel Vega-Badillo et al.   LIVER INTERNATIONAL

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fads1 and 2 are promoted to meet instant need for long-chain polyunsaturated fatty acids in goose fatty liver

(2016) Rashid H. Osman et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

microRNA–200b as a Switch for Inducible Adult Angiogenesis

(2015) Mithun Sinha et al.   ANTIOXIDANTS & REDOX SIGNALING

Western diet-induced hepatic steatosis and alterations in the liver transcriptome in adult Brown-Norway rats

(2015) Michael D. Roberts et al.   BMC GASTROENTEROLOGY

Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats

(2015) Dongmin Li et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease–related fibrosis

(2015) Fatjon Leti et al.   Translational Research

Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease

(2014) Yue Ying Feng et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice

(2014) L. Goedeke et al.   EMBO Molecular Medicine

3, 3′-diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance

(2014) Yun Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Therapeutic Silencing of MicroRNA-33 Inhibits the Progression of Atherosclerosis in Ldlr −/− Mice—Brief Report

(2013) Noemi Rotllan et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease

(2013) Tao Liu et al.   Evidence-based Complementary and Alternative Medicine

Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease

(2013) Cynthia A. Moylan et al.   HEPATOLOGY

Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease

(2013) April D. Lake et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

The ABCG5 ABCG8 Sterol Transporter Opposes the Development of Fatty Liver Disease and Loss of Glycemic Control Independently of Phytosterol Accumulation

(2012) Kai Su et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

(2012) Volodymyr P. Tryndyak et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease

(2011) A. D. Lake et al.   DRUG METABOLISM AND DISPOSITION

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

(2011) Katey J. Rayner et al.   JOURNAL OF CLINICAL INVESTIGATION

Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease

(2010) Anna Alisi et al.   LABORATORY INVESTIGATION

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease

(2010) Bilge Aktas et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Mapping and quantifying mammalian transcriptomes by RNA-Seq

(2008) Ali Mortazavi et al.   NATURE METHODS